Kosch Markus, Schaefer Roland M
Medizinische Poliklinik und Poliklinik D, Universitäts-Klinikum Münster, Münster, Deutschland.
Wien Klin Wochenschr. 2003 Jun 24;115(11):380-4. doi: 10.1007/BF03040356.
Absolute or functional iron deficiency is a common problem in chronic disease which may lead to iron-deficient erythropoesis. Moreover, lack of available iron is the most common reason for unresponsiveness to epoetin in patients on chronic dialysis. Measurements of serum ferritin, transferrin saturation and percentage of hypochromic red blood cells allow the assessment of iron status. Lack of iron resorption and dose-dependent side-effects limit oral supplementation in a number of patients. Several iron preparations are available for intravenous substitution, especially the newly registered iron-saccharose offers safe and reliable iron supplementation and reduces the risk of anaphylaxis and iron toxicity. This review discusses new guidelines concerning diagnosis of iron status, indication for therapy and application of intravenous iron preparation.
绝对铁缺乏或功能性铁缺乏是慢性病中的常见问题,可能导致缺铁性红细胞生成。此外,缺铁是慢性透析患者对促红细胞生成素无反应的最常见原因。血清铁蛋白、转铁蛋白饱和度和低色素红细胞百分比的测定有助于评估铁状态。铁吸收不足和剂量依赖性副作用限制了许多患者的口服补充。有几种铁制剂可用于静脉替代,特别是新注册的蔗糖铁提供了安全可靠的铁补充,并降低了过敏反应和铁毒性的风险。本文综述了有关铁状态诊断、治疗指征及静脉铁制剂应用的新指南。